Compounds > imatinib mesylate
Page last updated: 2024-09-03

imatinib mesylate and Hemorrhage, Retinal

imatinib mesylate has been researched along with Hemorrhage, Retinal in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's4 (57.14)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Chan, CK; Mohamed, S; Szeto, SK; Tsang, CW1
Agarwal, K; Paulose, RM; Rani, PK; Tyagi, M1
Auffarth, GU; Kaiser, D; Khoramnia, R; Marx, S; Scheuerle, A; Sel, S; Tandogan, T1
Kapadia, RK; Steeves, JH1
Gulati, AP; Saif, MW1
Christoforidis, JB; D'Amico, DJ; DeAngelo, DJ1
Bona, R; Kaplan, AA; Shafique, S1

Other Studies

7 other study(ies) available for imatinib mesylate and Hemorrhage, Retinal

ArticleYear
Massive retinal infiltrates as the presenting sign of chronic myeloid leukemia: Clinical and imaging features of leukemic retinopathy.
    European journal of ophthalmology, 2023, Volume: 33, Issue:1

    Topics: Animals; Chronic Disease; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Retina; Retinal Diseases; Retinal Hemorrhage; Vision Disorders

2023
Retinal haemorrhages: a clue to the underlying leukaemia.
    BMJ case reports, 2017, Sep-25, Volume: 2017

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Fluorescein Angiography; Fovea Centralis; Humans; Imatinib Mesylate; Leukemia, Myeloid, Acute; Male; Referral and Consultation; Retinal Hemorrhage; Tomography, Optical Coherence; Vision, Low; Visual Fields

2017
[Sudden bilateral decreased vision in a 14-year-old boy].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2017, Volume: 114, Issue:8

    Topics: Adolescent; Emergency Service, Hospital; Fundus Oculi; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Retinal Hemorrhage; Tomography, Optical Coherence; Vision Disorders; Vision, Binocular; Vision, Low

2017
Roth spots in chronic myelogenous leukemia.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2011, Dec-13, Volume: 183, Issue:18

    Topics: Adult; Antineoplastic Agents; Benzamides; Biopsy; Bone Marrow Cells; Diagnosis, Differential; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Retina; Retinal Hemorrhage

2011
Retinal neovascularization and hemorrhage associated with the use of imatinib (Gleevec(®)) in a patient being treated for gastrointestinal stromal tumor (GIST).
    Anticancer research, 2012, Volume: 32, Issue:4

    Topics: Antineoplastic Agents; Benzamides; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Piperazines; Pyrimidines; Retinal Hemorrhage; Retinal Neovascularization

2012
Resolution of leukemic retinopathy following treatment with imatinib mesylate for chronic myelogenous leukemia.
    American journal of ophthalmology, 2003, Volume: 135, Issue:3

    Topics: Antineoplastic Agents; Benzamides; Chronic Disease; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Piperazines; Pyrimidines; Retinal Hemorrhage; Retinal Neoplasms; Visual Acuity

2003
A case report of therapeutic leukapheresis in an adult with chronic myelogenous leukemia presenting with hyperleukocytosis and leukostasis.
    Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2007, Volume: 11, Issue:2

    Topics: Adult; Antineoplastic Agents; Benzamides; Blood Viscosity; Chronic Disease; Humans; Imatinib Mesylate; Leukapheresis; Leukemia, Myeloid; Leukocytosis; Leukostasis; Male; Piperazines; Pyrimidines; Retinal Hemorrhage

2007